Functional foods: Health boon or quackery? The FDA must get tough to safeguard consumers' health

Western Journal of Medicine

Volumn 172, Issue 1, 2000, Pages 8-9

  Jacobson, Michael F ^a   Silverglade, Bruce ^a   Heller, Ilene R ^a  

^a Center for Science in the Public Interest   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIET SUPPLEMENTATION; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH FOOD; QUACKERY; UNITED STATES;

FOOD, FORTIFIED; HEALTH FOOD; QUACKERY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0042730612     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.172.1.8     Document Type: Article

References (9)

1. Calcium: 21 C.F.R. § 101.72; Am J Clin Nutr 1991 Jul;54 (1 Suppl): 274S-280S; Calcium supplementation and bone loss: a review of controlled clinical trials. Dawson-Hughes B. Folate: 21 C.F.R. § 101.79; Lancet 1991 July 20;338(8760):131-7; Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Psyllium and oat bran: 21 C.F.R. § 101.81; Am J Nutr 1999 Jan;69(1):30-42; Cholesterol-lowering effects of dietary fiber; a meta-analysis. Brown L, Rosner B, Willett WW, Sacks FM.
2. Calcium: 21 C.F.R. § 101.72; Am J Clin Nutr 1991 Jul;54 (1 Suppl): 274S-280S; Calcium supplementation and bone loss: a review of controlled clinical trials. Dawson-Hughes B. Folate: 21 C.F.R. § 101.79; Lancet 1991 July 20;338(8760):131-7; Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Psyllium and oat bran: 21 C.F.R. § 101.81; Am J Nutr 1999 Jan;69(1):30-42; Cholesterol-lowering effects of dietary fiber; a meta-analysis. Brown L, Rosner B, Willett WW, Sacks FM.
3. Calcium: 21 C.F.R. § 101.72; Am J Clin Nutr 1991 Jul;54 (1 Suppl): 274S-280S; Calcium supplementation and bone loss: a review of controlled clinical trials. Dawson-Hughes B. Folate: 21 C.F.R. § 101.79; Lancet 1991 July 20;338(8760):131-7; Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Psyllium and oat bran: 21 C.F.R. § 101.81; Am J Nutr 1999 Jan;69(1):30-42; Cholesterol-lowering effects of dietary fiber; a meta-analysis. Brown L, Rosner B, Willett WW, Sacks FM.
4. Calcium: 21 C.F.R. § 101.72; Am J Clin Nutr 1991 Jul;54 (1 Suppl): 274S-280S; Calcium supplementation and bone loss: a review of controlled clinical trials. Dawson-Hughes B. Folate: 21 C.F.R. § 101.79; Lancet 1991 July 20;338(8760):131-7; Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Psyllium and oat bran: 21 C.F.R. § 101.81; Am J Nutr 1999 Jan;69(1):30-42; Cholesterol-lowering effects of dietary fiber; a meta-analysis. Brown L, Rosner B, Willett WW, Sacks FM.
5. Center for Science in the Public Interest. Functional foods - public health boon or 21st century quackery? an international comparison of regulatory requirements and marketing trends. Washington (DC): Center for Science in the Public Interest; 1999.
6. Letter from Joseph A Levitt, Director, Center for Food Safety and Applied Nutrition (CFSAN), FDA, to Brian D Perkins, President, McNeil Consumer Products Co., Oct 28, 1998; Letter from John B Foret, Director Division of Programs and Enforcement Policy, CFSAN, FDA to Myron Cooper, Vice President-Technical Services, Jun. 21 1999; Letter from Lynn Larsen, Director Division of Programs and Enforcement Policy, CFSAN, FDA to James A Taylor, Vice President of Marketing, The Dannon Company, Inc., Aug 6, 1999.
7. Warning letter from John B Foret, Director Division of Programs and Enforcement Policy, CFSAN, FDA to David Langer, Vice President, Langers Juice Co., Sept 28, 1999. Conclusion based on conversations with agency staffers.
8. Brown D. New FDA commissioner enters war over words. Washington Post March 26, 1999;A31.
9. Herbal Rx: the promises and pitfalls. Consumer Reports March 1999;44-48.